ANN ARBOR, Mich., June 30, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced that it will be included in the Russell Microcap® Index, according to information posted by Russell Investments on June 27, 2014. The final membership lists will be posted on June 30, 2014, with trading in the reconstituted indexes commencing that same day.
Help employers find you! Check out all the jobs and post your resume.
